Brief: Opthea Completes Enrollment In First Trial With Sozinibercept

Opthea

14/02/2024 11:21

Feb 14 (Reuters) - Opthea Ltd  OPT.AX :
    * OPTHEA LTD-  COMPLETES ENROLLMENT IN FIRST TRIAL WITH
SOZINIBERCEPT
    * OPTHEA LTD-  ENROLLMENT OF SECOND PIVOTAL TRIAL TO
COMPLETE IN
CALENDAR Q2 2024
    * OPTHEA LTD-  POSITIVE RESULTS FROM PHASE 2B STUDY OF
SOZINIBERCEPT MET PRE-SPECIFIED PRIMARY EFFICACY ENDPOINT
    * OPTHEA LTD-  SECONDARY OUTCOMES WERE POSITIVE FOR
COMBINATION
THERAPY WITH SOZINIBERCEPT
    * OPTHEA LTD- TOP-LINE RESULTS FROM TWO PHASE 3 PIVOTAL
TRIALS,
COAST AND SHORE, EXPECTED BY MID-2025

Source text for Eikon:  ID:n0000950170-24-014920 
Further company coverage:  OPT.AX 

 ((Reuters.Briefs@thomsonreuters.com;))